Galway Group Life Sciences Consulting

Galway Group is a boutique Life Sciences advisory firm focused exclusively on Patient Support and access strategy. We help manufacturers design, launch, and optimize Patient Support operating models that work in the real world, especially in high-friction categories where access determines whether Patients ever start or stay on therapy. The science should be the hard part. Getting medication to the Patient should not be. Galway Group partners with executive teams in oncology, rare and orphan disease, genomic medicines, and biosimilars to answer three fundamental questions: Can Patients start and stay on therapy without unnecessary friction? Are Patient Support investments aligned with real-world provider and Patient behavior? Does the operating model respect compliance, gross-to-net impact, and capital realities? Our work spans the full Patient Support ecosystem, including: Buy and bill, medical benefit, and specialty pharmacy models Hub strategy, copay and Patient Assistance programs, and free goods Field Reimbursement and Nurse Educator models Vendor selection, governance, KPIs, SLAs, and escalation frameworks Galway Group is known for senior-led, outcome-focused work. There is no junior bench, no staff augmentation, and no slide factory. Clients work directly with experienced leadership to pressure-test assumptions, validate strategy, and make defensible decisions. Engagements are typically structured as fixed-fee strategy sprints, launch readiness initiatives, or standing advisory retainers for a limited number of clients. Galway Group was founded by Maureen Dolan Bala and is named for her mother, who left Ireland’s west coast for Boston. The firm reflects that same ethos: practical, principled, and built to last.